Daiwa Securities Group Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,307
Total Value
15007955
Accession Number
0001481045-25-000006
Form Type
13F-HR
Manager Name
Daiwa Securities Group Inc.
Data Enrichment
93% identified
1,218 identified89 unidentified

Holdings

1,307 positions
Manager:
Search and click to pin securities to the top
Page 59 of 64
AbCellera Biologics Inc.
Shares:
1151(+0.0%)
Value:
$3.0K(+0.0%)
81369Y605
Shares:
67(-14.1%)
Value:
$3.0K(-25.0%)
Nurix Therapeutics, Inc.
Shares:
245(+0.0%)
Value:
$3.0K(-40.0%)
Evolus, Inc.
Shares:
262(+0.0%)
Value:
$3.0K(+0.0%)
ANAVEX LIFE SCIENCES CORP.
Shares:
314(+0.0%)
Value:
$3.0K(+0.0%)
10x Genomics, Inc.
Shares:
370
Value:
$3.0K
Bitdeer Technologies Group
Shares:
250(-50.0%)
Value:
$3.0K(-80.0%)
AVADEL PHARMACEUTICALS PLC
Shares:
332(+0.0%)
Value:
$3.0K(+0.0%)
Enliven Therapeutics, Inc.
Shares:
152(+0.0%)
Value:
$3.0K(+0.0%)
Grifols SA
Shares:
398(+0.0%)
Value:
$3.0K(+0.0%)
HARROW, INC.
Shares:
110(+0.0%)
Value:
$3.0K(-25.0%)
GRAIL, Inc.
Shares:
98(+0.0%)
Value:
$3.0K(+50.0%)
Spyre Therapeutics, Inc.
Shares:
206
Value:
$3.0K
CASTLE BIOSCIENCES INC
Shares:
86(+0.0%)
Value:
$2.0K(+0.0%)
Mineralys Therapeutics, Inc.
Shares:
152(+0.0%)
Value:
$2.0K(+0.0%)
Absci Corp
Shares:
600
Value:
$2.0K
Phathom Pharmaceuticals, Inc.
Shares:
260(+0.0%)
Value:
$2.0K(+0.0%)
464287457
Shares:
19(-89.4%)
Value:
$2.0K(-86.7%)
Theravance Biopharma, Inc.
Shares:
215(+0.0%)
Value:
$2.0K(+0.0%)
CureVac N.V.
Shares:
697(+0.0%)
Value:
$2.0K(+0.0%)